Clinical trial
Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving…
NCT00237575 · University of Kentucky, Other · Terminated
Key facts
| NCT number | NCT00237575 |
|---|---|
| Title | Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer |
| Official title | A Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin and Gemcitabine for Regionally Advanced or Metastatic Urothelial Cancer |
| Lead sponsor | University of Kentucky, Other |
| Collaborators | Bayer Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bladder Cancer |
| Intervention type | Drug |
| Interventions | gemcitabine, cisplatin, sargramostim, filgrastim |
| Enrollment | 100 |
| Start date | Nov 1, 2005 |
| Primary completion | Mar 1, 2006 |
| Completion | Mar 1, 2006 |
| First posted | Oct 12, 2005 |
| Last update posted | May 23, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: